Literature DB >> 29786833

Assessment of cerebral perfusion and edema in preeclampsia with intravoxel incoherent motion MRI.

Maria Nelander1, Daniel Hannsberger2, Inger Sundström-Poromaa1, Lina Bergman1,3, Jan Weis2,4, Helena Åkerud1,5, Johan Wikström2, Anna-Karin Wikström1.   

Abstract

INTRODUCTION: Cerebral complications are the main reasons for morbidity and mortality in preeclampsia and eclampsia. As yet, we do not know whether the pathophysiology entails hypo- or hyperperfusion of the brain, or how and when edema emerges, due to the difficulty of examining the cerebral circulation.
MATERIAL AND METHODS: We have used a non-invasive diffusion weighted-magnetic resonance imaging technique, intravoxel incoherent motion, to study cerebral perfusion on the capillary level and cerebral edema in women with preeclampsia (n = 30), normal pregnancy (n = 32), and non-pregnant women (n = 16). Estimates of cerebral blood volume, blood flow, and edema were measured in 5 different regions. These points were chosen to represent blood supply areas of both the carotid and vertebrobasilar arteries, and to include both white and gray matter.
RESULTS: Except for the caudate nucleus, we did not detect any differences in cerebral perfusion measures on a group level. In the caudate nucleus, we found lower cerebral blood volume and lower blood flow in preeclampsia than in either normal pregnancy (P = .01 and P = .03, respectively) or non-pregnant women (both P = .02). No differences in edema were detected between study groups.
CONCLUSION: The cerebral perfusion measures were comparable between the study groups, except for a portion of the basal ganglia where hypoperfusion was detected in preeclampsia but not in normal pregnancy or non-pregnant women.
© 2018 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  cerebral circulation; eclampsia; edema; intravoxel incoherent motion; magnetic resonance imaging; perfusion; preeclampsia

Mesh:

Year:  2018        PMID: 29786833     DOI: 10.1111/aogs.13383

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  6 in total

1.  Oxygen extraction fraction (OEF) assesses cerebral oxygen metabolism of deep gray matter in patients with pre-eclampsia.

Authors:  Linfeng Yang; Junghun Cho; Tao Chen; Kelly M Gillen; Jing Li; Qihao Zhang; Lingfei Guo; Yi Wang
Journal:  Eur Radiol       Date:  2022-03-29       Impact factor: 7.034

Review 2.  Investigating Maternal Brain Alterations in Preeclampsia: the Need for a Multidisciplinary Effort.

Authors:  Lina Bergman; Pablo Torres-Vergara; Jeffrey Penny; Johan Wikström; Maria Nelander; Jose Leon; Mary Tolcher; James M Roberts; Anna-Karin Wikström; Carlos Escudero
Journal:  Curr Hypertens Rep       Date:  2019-08-02       Impact factor: 5.369

3.  Expression Level of IL-17 in Peripheral Blood of Patients with Late Pregnancy and Diagnosis of Maternal-Fetal Tolerance Based on Brain MRI Image Segmentation Algorithm.

Authors:  Zenying Yu; Shengyan Zhou; Zhen Tan; Guangmin Lu
Journal:  Pak J Med Sci       Date:  2021       Impact factor: 1.088

4.  Cerebral Biomarkers and Blood-Brain Barrier Integrity in Preeclampsia.

Authors:  Therese Friis; Anna-Karin Wikström; Jesenia Acurio; José León; Henrik Zetterberg; Kaj Blennow; Maria Nelander; Helena Åkerud; Helena Kaihola; Catherine Cluver; Felipe Troncoso; Pablo Torres-Vergara; Carlos Escudero; Lina Bergman
Journal:  Cells       Date:  2022-02-24       Impact factor: 6.600

5.  Prediction of pre-eclampsia by using radiomics nomogram from gestational hypertension patients.

Authors:  Xue-Fei Liu; Jing-Jing Lu; Meng-Die Li; Ying Li; An-Rong Zeng; Jin-Wei Qiang
Journal:  Front Neurosci       Date:  2022-08-05       Impact factor: 5.152

6.  Severe pre-eclamptic women with headache: is posterior reversible encephalopathy syndrome an associated concurrent finding?

Authors:  An-Shine Chao; Yao-Liang Chen; Yao-Lung Chang; Angel Chao; Seng-Yuan Su; Tzu-Hao Wang
Journal:  BMC Pregnancy Childbirth       Date:  2020-06-01       Impact factor: 3.007

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.